The vascular biology of the glycoprotein Ib-IX-V complex

Thrombosis and Haemostasis

Volumn 86, Issue 1, 2001, Pages 178-188

  Berndt, M C ^a   Shen, Y ^a   Dopheide, S M ^a   Gardiner, E E ^a   Andrews, R K ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

GP Ib IX V complex; Platelet activation; Signaling; Thrombosis; Von Willibrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 12; CD11B ANTIGEN; FIBRINOGEN RECEPTOR; HIGH MOLECULAR WEIGHT KININOGEN; LIGAND; PADGEM PROTEIN; PLATELET GLYCOPROTEIN IB IX V COMPLEX; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; SNAKE VENOM; THROMBIN; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANGIOPLASTY; BINDING SITE; BLOOD VESSEL; CELL INTERACTION; CONFERENCE PAPER; CYTOSKELETON; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; LEUKOCYTE; LIGAND BINDING; MACROPHAGE MIGRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOSIS; THROMBUS;

EID: 0034923236     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616216     Document Type: Conference Paper

References (123)

1. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: The involvement of glycoprotein VI in the platelet adhesion
2. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
3. Initiation of platelet adhesion by arrest onto fibrinogen or translocation of von Willebrand factor
4. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
5. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex
6. Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GPIb/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear
7. A mouse model of severe von Willebrand disease: Defects in haemostasis and thrombosis
8. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa
9. Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress
10. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets
11. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions
12. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: Distinct shear-dependent roles of platelet receptors and adhesive proteins under flow
13. A revised model of platelet aggregation
14. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction
15. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin
16. Platelet-endothelial interactions in inflamed mesenteric venules
17. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin
18. P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo
19. Selectins and their ligands: Current concepts and controversies
20. P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia
21. P-selectin mediates the interaction of circulating leukocytes with platelets and micro-vascular endothelium in response to oxidized lipoprotein in vivo
22. Immunoneutralization of glycoprotein Ibalpha attenuates endotoxin- induced interactions of platelets and leukocytes with rat venular endothelium in vivo
23. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins
24. Adhesion of activated platelets to endothelial cells: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha
25. Identification of an active sequence within the first immunoglobulin domain of intercellular cell adhesion molecule-1 (ICAM-1) that interacts with fibrinogen
26. A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1
27. Defects in haemostasis in P-selectin-deficient mice
28. Bernard-Soulier syndrome
29. Fibrid-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor
30. Molecular mechanisms of platelet adhesion and activation
31. Structure and function of the glycoprotein Ib-IX-V complex
32. The glycoprotein Ib complex of human blood platelets
33. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane
34. Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane
35. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane
36. Cloning of the alpha chain of human platelet glycoprotein Ib: A transmembrane protein with homology to leucine-rich alpha 2-glycoprotein
37. Structure of the glycoprotein Ib.IX complex from platelet membranes
38. Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein Ib
39. Platelet glycocalicin. II. Purification and characterization
40. Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications
41. The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine 145
42. Tyrosine sulfation of the glycoprotein Ib-IX complex: Identication of sulfated residues and effect on ligand binding
43. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin
44. Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alpha-thrombin binding
45. Identification of a region in the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX complex that binds to purified actin-binding protein
46. Identification of a binding sequence for the 14-3-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ib alpha
47. Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex
48. The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence
49. Human platelet glycoprotein IX: An adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures
50. Platelet glycoprotein Ib beta is phosphorylated on serine 166 by cyclic AMP-dependent protein kinase
51. Cyclic AMP-dependent phosphorylation of glycoprotein Ib inhibits collagen-induced polymerization of actin in platelets
52. Human signaling protein 14-3-3 zeta interacts with platelet glycoprotein Ib subunits Ibalpha and Ibbeta
53. Cytoplasmic domains of GpIbalpha and GpIbbeta regulate 14-3-3 zeta binding to GpIb/IX/V
54. Human platelet glycoprotein V: Characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins
55. Human platelet glycoprotein V: Its role in enhancing expression of the glycoprotein Ib receptor
56. Structure and function of von Willebrand factor
57. Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha
58. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor
59. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin
60. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib
61. A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib
62. Structure and function of the von Willebrand factor A1 domain: Analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation
63. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib
64. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex
65. Antiplatelet glycoprotein Ib monoclonal antibody (OP-F1) totally abolishes ristocetin-induced von Willebrand factor binding, but has minimal effect on the botrocetin-induced binding
66. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions
67. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and Ristocetin/Botrocetin-induced glycoprotein Ib-von Willebrand factor interaction
68. Aggregation of mammalian cells expressing the platelet glycoprotein (GP) Ib-IX complex and the requirement for tyrosine sulfation of GP Ib alpha
69. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding
70. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling
71. Novel gain-of-function mutations of platelet glycoprotein Ibalpha by valine mutagenesis in the Cys209-Cys248 disulphide loop. Functional analysis under statis and dynamic conditions
72. Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field
73. Necessity of conserved asparagine residues in the leucine-rich repeats of platelet glycoprotein Ib alpha for the proper conformation and function of the ligand-binding region
74. Platelet glycoprotein Ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)
75. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding
76. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin
77. Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregations
78. The platelet glycoprotein Ib-IX complex
79. Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha-thrombin
80. The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III
81. High-affinity alpha-thrombin binding to platelet glycoprotein Ib alpha: Identification of two binding domains
82. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha
83. Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation
84. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib
85. Glycoprotein Ib alpha peptides inhibit thrombin and SFLLRN-induced platelet aggregation
86. Interaction of thrombin with platelets: Purification of the thrombin substrate
87. Binding of thrombin to the Glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets
88. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein
89. Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site
90. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity
91. Platelet glycoprotein Ib-alpha binds to thrombin anion-binding exosite II inducing allosteric changes in thrombin's activity
92. Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation
93. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex
94. Platelet glycoprotein Ib: A zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen
95. Snake venom modulators of platelet adhesion receptors and their ligands
96. Snake venom proteases affecting haemostasis and thrombosis
97. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib
98. Are C-type lectin-related proteins derived by proteolysis of metalloproteinase/disintegrin precursor proteins?
99. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation
100. Alboaggregins A and B. Structure and interaction with human platelets
101. Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets
102. Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naha kaouthia cobra venom
103. Platelets and shear stress
104. Integrin alpha IIb beta 3 and platelet function
105. Von Willebrand factor binding to platelet GPIb initiates signals for platelet activation
106. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation
107. Adhesion receptor activation of phosphatidylinositol 3-kinase. Von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets
108. Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s)
109. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate
110. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor
111. Rap1B and Rap2B translocation to the cytoskeleton by von Willebrand factor involves FegammaII receptor-mediated protein tyrosine phosphorylation
112. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fe receptor FegammaRIIA on the platelet plasma membrane
113. Collagen receptor signaling in platelets and megakaryocytes
114. A novel association of Fe receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets
115. Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX- mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model
116. Association of a phospholipase A2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex
117. The cytoplasmic domain of the platelet glycoprotein Ibalpha is phosphorylated at serine 609
118. Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3zeta
119. The cytoplasmic domain of the alpha-subunit of glycoprotein (GP) Ib mediates attachment of the entire GP Ib-IX complex to the cytoskeleton and regulates von Willebrand factor-induced changes in cell morphology
120. Thrombin-induced GPIb-IX centralization on the platelet surface requires actin assembly and myosin II activation
121. The platelet cytoskeleton
122. The von Willebrand factor-glycoprotein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells
123. Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von Willebrand factor interaction